Rankings
▼
Calendar
IONS Q4 2024 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$13B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$227M
-30.2% YoY
Gross Profit
$223M
98.3% margin
Operating Income
-$111M
-48.9% margin
Net Income
-$104M
-46.1% margin
EPS (Diluted)
$-0.66
QoQ Revenue Growth
+69.3%
Cash Flow
Operating Cash Flow
-$116M
Free Cash Flow
-$142M
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$3.0B
Total Liabilities
$2.4B
Stockholders' Equity
$588M
Cash & Equivalents
$242M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$227M
$325M
-30.2%
Gross Profit
$223M
$321M
-30.7%
Operating Income
-$111M
-$6M
-1709.9%
Net Income
-$104M
-$9M
-1026.5%
Revenue Segments
Research and Development Revenue
$201M
31%
Collaborative Agreement Revenue
$146M
23%
Commercial
$145M
23%
SPINRAZA Royalties
$102M
16%
Other Commercial
$32M
5%
Product
$17M
3%
← FY 2024
All Quarters
Q1 2025 →